Concepedia

Sergio Amadori

SA

Statistics

Publications

250

Citations

23.3K

H-Index

74

Active since

1977

Affiliations

University of Rome Tor Vergata(Current)

Sapienza University of Rome

St. Eugenio Hospital

Radboud University Nijmegen

Fondazione Gimema Onlus

Sergio Amadori is an author at University of Rome Tor Vergata specializing in medicine, oncology, and hematology.

ORCID

Publications per year

1977–2024

250

Publications

250

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

, , +16

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

, , +17

Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia

Giampaolo Bucaneve, Alessandra Micozzi, Francesco Menichetti et al. · New England Journal of Medicine · 2005 · 647 citations · Full text

, , +13

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura

Roberto Stasi, Adalberto Pagano, Elisa Stipa et al. · Blood · 2001 · 549 citations · Full text

, , +12

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab

Roberto Stasi, Nichola Cooper, Giovanni Del Poeta et al. · Blood · 2008 · 406 citations

, , +14

1–5 of 250